Syphilis Testing Market To Witness Incremental Growth At 5.6% CAGR To Surpass $1.9 Billion By The End Of 2030

(MENAFN- EIN Presswire)

Increase in the occurrence of sexually transmitted disease and technological advancements drive the growth of syphilis testing market.

PORTLAND, OREGON, UNITED STATES, August 23, 2022 /EINPresswire.com / -- According to a new report published by Allied market Research, titled,“Syphilis Testing Market ,' The syphilis testing market was valued at $1.1 billion in 2020, and is estimated to reach $1.9 billion by 2030, growing at a CAGR of 5.6% from 2021 to 2030.

Download Sample PDF at:

Syphilis is a sexually transmitted disease caused by the bacteria Treponema pallidum. Syphilis tests are used to diagnose and detect antibodies against the bacteria in a patient's blood. There are various problems associated with syphilis such as male infertility, ectopic pregnancy, cervical cancer in women, and mortality from disease. Treponemal tests used to diagnose bacterial infections include Treponema pallidum particle agglutination (TP-PA) and fluorescent treponemal antibody (FTA-ABS). Non-treponemal tests are easy to perform and interpret, provide quick results, and are inexpensive. However, non-treponemal tests require laboratory equipment and trained personnel to perform and interpret test reactions. Non-treponemal tests include Rapid Plasma Reagin (RPR), which is a form of the Venereal Disease Research Laboratory (VDRL) test, and tests for specific antigens.

COVID-19 scenario -

The outbreak of the Covid-19 pandemic negatively impacted the global syphilis testing market. This is owing to decrease in the number of patient visits to hospitals and clinics for testing, as a result of the suspension of various elective procedures and outpatient visits, which reduced the demand for syphilis tests.

Between March 2019 and May 2020, the Syphilis testing rate fell by 64%.

Drivers, restraints, and opportunities -

Increase in the occurrence of sexually transmitted disease including syphilis and technological advancements drive the growth of syphilis testing market. However, high proportion of health and economic burden for the developing countries due to Syphilis and avoidance and refraining from voluntary / CICT Syphilis testing hinder the uptake of diagnostic tests or testing volume, thus restraining the growth of the syphilis testing market. Moreover, rapid development in diagnostic kits, improved healthcare infrastructure, and availability of test kits are expected to create opportunities for market growth during the forecast period.

Specific Requirement on COVID-19? Ask to Our Industry Expert:

Leading market players-

Becton Dickinson And Company
Hologic, Inc.
Cepheid Inc.
DiaSorin
Abbott Laboratories
Bio-Rad Laboratories
Beckman Coulter Inc
F. Hoffmann-La Roche
Affymetrix, Inc
Siemens healthcare

The laboratory testing segment held the lion's share in 2020 -

Based on location of testing, the laboratory testing segment held the lion's share in 2020, contributing to more than four-fifths of the global syphilis testing market, and is expected to continue its lead during the forecast period. However, thepoint of care (POC) testing segment is expected to witness the highest CAGR of 6.8% by 2030, due to increase in prevalence of syphilis infection, the laboratory test is cost efficient, convenient and confidential for use in hospitals & clinics.

North America, to lead the trail in terms of revenue -

By region, North America, garnered the major share in 2020, contributing to more than one-third of the global syphilis testing market and is expected to dominate the market during the forecast period. However, LAMEA region is expected grow at the fastest CAGR of 6.2% by 2030.

Trending Reports in Healthcare Industry:

Cell Therapy Market:

Disposable Gloves Market:

Electrocardiograph (ECG) Market:

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of 'Market Research Reports' and 'Business Intelligence Solutions.' AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

MENAFN23082022003118003196ID1104743436